Format

Send to

Choose Destination
PLoS One. 2018 Feb 14;13(2):e0192809. doi: 10.1371/journal.pone.0192809. eCollection 2018.

Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.

Wilson SE1,2,3, Chung H2, Schwartz KL1,2,3, Guttmann A2,4,5, Deeks SL1,3, Kwong JC1,2,3,6, Crowcroft NS1,3,7, Wing L2, Tu K2,5,6.

Author information

1
Public Health Ontario, Toronto, Ontario, Canada.
2
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
3
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
4
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
5
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
6
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
7
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Abstract

BACKGROUND:

In August 2011, Ontario, Canada introduced a rotavirus immunization program using Rotarix™ vaccine. No assessments of rotavirus vaccine coverage have been previously conducted in Ontario.

METHODS:

We assessed vaccine coverage (series initiation and completion) and factors associated with uptake using the Electronic Medical Record Administrative data Linked Database (EMRALD), a collection of family physician electronic medical records (EMR) linked to health administrative data. Series initiation (1 dose) and series completion (2 doses) before and after the program's introduction were calculated. To identify factors associated with series initiation and completion, adjusted odds ratios (aOR) and 95% confidence intervals (95%CI) were calculated using logistic regression.

RESULTS:

A total of 12,525 children were included. Series completion increased each year of the program (73%, 79% and 84%, respectively). Factors associated with series initiation included high continuity of care (aOR = 2.15; 95%CI, 1.61-2.87), maternal influenza vaccination (aOR = 1.55; 95%CI,1.24-1.93), maternal immmigration to Canada in the last five years (aOR = 1.47; 95% CI, 1.05-2.04), and having no siblings (aOR = 1.62; 95%CI,1.30-2.03). Relative to the first program year, infants were more likely to initiate the series in the second year (aOR = 1.71; 95% CI 1.39-2.10) and third year (aOR = 2.02; 95% CI 1.56-2.61) of the program. Infants receiving care from physicians with large practices were less likely to initiate the series (aOR 0.91; 95%CI, 0.88-0.94, per 100 patients rostered) and less likely to complete the series (aOR 0.94; 95%CI, 0.91-0.97, per 100 patients rostered). Additional associations were identified for series completion.

CONCLUSIONS:

Family physician delivery achieved moderately high coverage in the program's first three years. This assessment demonstrates the usefulness of EMR data for evaluating vaccine coverage. Important insights into factors associated with initiation or completion (i.e. high continuity of care, smaller roster sizes, rural practice location) suggest areas for research and potential program supports.

PMID:
29444167
PMCID:
PMC5812625
DOI:
10.1371/journal.pone.0192809
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center